Lapin I P
Eur J Pharmacol. 1981 May 22;71(4):495-8. doi: 10.1016/0014-2999(81)90195-3.
L-glycine (1-12.5 micrograms, intracerebroventricularly, i.c.v.) completely prevented seizures induced by i.c.v. administration of L-kynurenine, and practically did not modify those induced by another convulsant quinolinic acid, a metabolite of tryptophan, and by strychnine. L-Glycine administered intraperitoneally (i.p.) (1000 mg/kg) decreased lethality after K-kynurenine and quinolinic acid; at doses of 3000 and 4000 mg/kg which are sedative and hypothermic it prolonged the latency of strychnine and L-kynurenine seizures. The convulsant action of pentylenetetrazol was not modified. Kynurenine seizures are suggested to be related to the action of kynurenine on glycine receptors in the central nervous system.
L-甘氨酸(1 - 12.5微克,脑室内注射,i.c.v.)完全预防了脑室内注射L-犬尿氨酸诱导的癫痫发作,并且实际上并未改变由另一种惊厥剂喹啉酸(色氨酸的一种代谢产物)和士的宁诱导的癫痫发作。腹腔注射(i.p.)L-甘氨酸(1000毫克/千克)降低了犬尿氨酸和喹啉酸后的致死率;在具有镇静和体温过低作用的3000和4000毫克/千克剂量下,它延长了士的宁和L-犬尿氨酸癫痫发作的潜伏期。戊四氮的惊厥作用未改变。提示犬尿氨酸癫痫发作与犬尿氨酸对中枢神经系统中甘氨酸受体的作用有关。